Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial

Division of Genetics and Developmental Behavior, Durham

Medical Univ of South Carolina, Charleston

Road Runner Research, Atlanta

Miami Children's Hospital - Medical Genetics and Neuro-Developmental Center, Miami

Phoenix Children's Hospital, Miami

Northwest Clinical Research Center, West Palm Beach

Clinical Studies Centers, LLC, St. Petersburg

Neufeld Medical Group, Inc., Fort Myers

Valko and Associates, Toledo

Metrohealth Medical Center, Cleveland

Hurley Medical Center, Flint

Saint Mary's Health Care, Grand Rapids

Washington University School of Medicine, Grand Rapids

Northwest Clinical Research Center, St Louis

Meridien Research, Lincoln

Child Neurology Associates, PC, Little Rock

Office of Lazlo Mate, Tulsa

Down Syndrome Clinic of Houston, Houston

Alamo City Clinical Research, LLC, San Antonio

Community Research Foundation, San Antonio

Rocky Mountain Pediatrics, P.C., Lakewood

Phoenix Children's Hospital, Phoenix

Midwest Children's Health Research Institute, Los Angeles

UCSD Pediatric Pharmacology Research Unit, San Diego

University of California, Irvine Medical Center, Orange

Children's Hospital and Research Center at Oakland, Oakland

Neuropsychiatric Research Center of Southwest Florida, Bellevue

Miami Children's Hospital, Miami

Regions Hospital, Saint Paul

Clinical Research Center of New Jersey, Voorhees Township

Vanderbilt Children's Hospital, Nashville